0

Back to Immune-Related Adverse Events Secondary to Checkpoint-Inhibitor Therapy
Immune-Related Adverse Events Secondary to Checkpoint-Inhibitor Therapy

Immune-Related Adverse Events Secondary to Checkpoint-Inhibitor Therapy

This case based online course will discuss common immune-related adverse events (irAEs) in patients undergoing immunotherapy, addressing the following topics:  irAEs onset and frequency; reporting of irAEs in pathology reports; coverage of hepatic, pancreatic, cutaneous, and cardiac irAEs and their management and outcomes; and detailed discussion of patterns of injury in the gut for gastrointestinal irAEs.

 

The activity offers 1.0 CME, CMLE, or SAMs CME credit.

  • List Price: $0.00 USD

Item Details:

The rapid rate of breakthroughs in immuno-oncology has outpaced continuing education in medicine, leaving pathologists and laboratory teams without optimal awareness about the core science of pan-tumor immuno-oncology checkpoints, biomarkers, pathways, and therapeutics. A growing body of research...

Back to Immune-Related Adverse Events Secondary to Checkpoint-Inhibitor Therapy
View More

Bought This Bought That ...